The University of Michigan National Poll on Healthy Aging recently conducted the survey focusing on the concerns of adults aged 50 and above regarding various health-related issues in their communities.
At no surprise, healthcare costs were listed as the top concern among older adults, with 56% of participants in a survey expressing high concern about the cost of medical care.
The University of Michigan National Poll on Healthy Aging recently conducted the survey focusing on the concerns of adults aged 50 and above regarding various health-related issues in their communities.
The findings shed light on the main worries surrounding access to affordable, high-quality healthcare, among other concerns.
While healthcare costs were presented as the highest concern among older adults, similarly, the cost of home care, assisted living, or nursing home care and prescription medications ranked high on the list, each garnering 56% and 54% of respondents' very high concerns, according to the study.
A report from the Center for Retirement Research at Boston College revealed that a notable portion of older used their retirement savings and Social Security benefits to pay for medical expenses when retiring.
According to the 2022 Fidelity Retiree Health Care Cost Estimate, the average retired couple at age 65 can expect to spend around $315,000 on healthcare expenses in retirement.
With these concerning costs, others were observed across various demographic groups, including gender, age, race/ethnicity, education level, income, political ideology and geographic location.
This highlights the effects of healthcare costs and financial scams and fraud on older adults' well-being and financial security.
Additionally, disparities were apparent when examining concerns across racial and ethnic groups.
For example, Black and Hispanic respondents were more likely to express high concern about discrimination by age or race and unequal access to healthcare, emphasizing the need to address inequalities within the healthcare system.
Gender and age differences were also a notable finding in the survey, with women and younger respondents aged 50–64 feeling a heightened concern about financial scams and fraud, dental care costs and social isolation.
Understanding these differences can help create targeted interventions and support services that meet the needs of different demographic groups, authors suggest.
Authors also noted the study highlights the need for policymakers, healthcare professionals and community organizations to tackle the challenges of healthcare affordability and access facing older adults.
Efforts to contain healthcare costs and combat financial scams and fraud must be prioritized, with programs like the State Health Insurance Assistance Programs (SHIPs) playing a vital role in providing information and resources to help older adults navigate their healthcare options and mitigate expenses, authors suggest.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More